Financials
- Fiscal year
- 2025
- Total assets
- €1.4m
- Profit
- €324,927
- Solvency
- 66.8%
Total assets▲ 8.7%
Net result
20192025
DR. KATRIEN VOSSAERT
ActiveSummary
DR. KATRIEN VOSSAERT has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €935,458 and a net result of €324,927. Equity is growing by ~5.7% per year across the filed fiscal years. Its solvency ranks better than 53% of 18230 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Overview
Activity
Human health activities
NACE 86109NACE 85120Specialist medical practice NACE 86220
2 sites
Size
€1.4mtotal assets 2025
- Staff
- 8.8 FTE
- Equity
- €935,458
- Profit
- €324,927
Turnover not published (abridged schema)
Structure
Accounts 40 d early0 of 3 deeds read
Why 93+ Sector Human health activities (NACE 86)+ Size: total assets €1.4m+ Liquidity: current ratio 2.86, cash €229,313+ Equity €935,458 (66.8% of total assets)Show the evidence
Checked score
Score 2025
93
/ 100
Excellent
Probability in this band: under 0.55%
Better than 47% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency
92-2
equity 66.8% of total assets
Liquidity
56-1
short-term debt 32.4% · cash 16.4%
Profitability
98+7
return on assets 23.2%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 12 months
11-2025: < 0.1%highest value
12-2025: < 0.1%● 0.0% vs 11-2025highest value
01-2026: < 0.1%▼ -7.7% vs 12-2025lowest value
02-2026: < 0.1%● 0.0% vs 01-2026lowest value
03-2026: < 0.1%● 0.0% vs 02-2026lowest value
04-2026: < 0.1%● 0.0% vs 03-2026lowest value
05-2026: < 0.1%● 0.0% vs 04-2026lowest value
06-2026: < 0.1%● 0.0% vs 05-2026lowest value
07-2026: < 0.1%● 0.0% vs 06-2026lowest value
08-2026: < 0.1%● 0.0% vs 07-2026lowest value
09-2026: < 0.1%▲ +4.2% vs 08-2026
10-2026: < 0.1%▲ +4.0% vs 09-2026highest value
- Sector Human health activities (NACE 86) lowers the probability
- Size: total assets €1.4m lowers the probability for this profile
- Liquidity: current ratio 2.86, cash €229,313 lowers the probability
- Equity €935,458 (66.8% of total assets) lowers the probability
Credit up to €85,000 at 30 days acceptable
Liquidity ample (current ratio 2.86 against 2.98 in 2024; short-term debt: 32.4% and cash: 16.4% of total assets), and 33.2% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 54%, liquidity 32%, profitability 58%, growth against the median 44%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 22-12-2025, 40 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
40 d early
2024
39 d early
2023
1 d early
2022
on the day
2021
3 d early
2020
24 d early
2019
8 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 16 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 28 January (4 of the last 5 filed years within 36 days of that day).
Companies Code · seven monthsPosition in the running window
30-06-2026 close02-10-2026 today31-01-2027 deadline
- Annual accounts filedfiscal year 2025 · micro…
- Highest result since 2019net €324,927 ▲39.4%
- Annual accounts filedfiscal year 2024 · micro…
Key points
- Positive: Among the best 5% on net resultsector median €60,729 · 18,219 companies €324,927 View
- Positive: Always filed on timeaccounts within the deadline every year 8 years View
- Positive: 7 profitable years in a rowprofit 2025: €324,927 7 years View
- Positive: Result rose in 2025from €233,071 to €324,927 ▲ 39.4% View
By topic
Timeline
- Events
- 13
- Since
- 2016
- Next accounts
- by 31-01-2027
- 22-12-2025Annual accounts filed
- 30-06-2025Highest result since 2019
- 23-12-2024Annual accounts filed
Company details
- Sites
- 2
- Legal form
- Private limited company
- Activity
- Human health activitiesNACE 86109
- Founded
- 03-04-2000
- Year ends
- 30-06
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.